Updated results of a phase III trial comparing standard thoracic radiotherapy (RT) with or without concurrent daily low-dose carboplatin in elderly patients (pts) with locally advanced non-small cell lung cancer (NSCLC): JCOG0301.
Hiroaki Okamoto
Honoraria - Aventis; Chugai Pharma; Janssen-Ortho; Kyowa Hakko Kirin; Lilly; Taiho Pharmaceutical
Shinji Atagi
No relevant relationships to disclose
Masaaki Kawahara
No relevant relationships to disclose
Akira Yokoyama
No relevant relationships to disclose
Nobuyuki Yamamoto
No relevant relationships to disclose
Yuichiro Ohe
No relevant relationships to disclose
Toshiyuki Sawa
No relevant relationships to disclose
Tetsu Shinkai
No relevant relationships to disclose
Kiyoshi Mori
No relevant relationships to disclose
Koji Takeda
No relevant relationships to disclose
Masao Harada
No relevant relationships to disclose
Kazuhiko Nakagawa
No relevant relationships to disclose
Naruo Yoshimura
No relevant relationships to disclose
Yoshio Tomizawa
No relevant relationships to disclose
Yuichiro Takeda
No relevant relationships to disclose
Haruhiko Fukuda
No relevant relationships to disclose
Taro Shibata
No relevant relationships to disclose
Satoshi Ishikura
No relevant relationships to disclose
Nagahiro Saijo
No relevant relationships to disclose
Tomohide Tamura
Honoraria - Bristol-Myers Squibb